# The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.

> **NCT01891435** · NA · COMPLETED · sponsor: **Hamad Medical Corporation** · enrollment: 434 (actual)

## Conditions studied

- Fever
- Reduction in Temperature

## Interventions

- **DRUG:** Oral paracetamol
- **DRUG:** Intravenous paracetamol
- **DRUG:** Intramuscular diclofenac

## Key facts

- **NCT ID:** NCT01891435
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-12
- **Final completion:** 2013-04
- **Target enrollment:** 434 (ACTUAL)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891435, "The Antipyretic Efficacy of Oral and Intravenous Paracetamol and Intramuscular Diclofenac in Patients Presenting With Fever.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01891435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*